Förstl, H.[Symptomatic therapy of Alzheimer dementia]..Wien Med Wochenschr.2002.152.3-4.77-80

Diehl, J;Grimmer, T;Förstl, H;Kurz, A;Drzezga, A;Schwaiger, M.Association of apathy with cerebral glucose metabolism in frontotemporal dementia.Neurobiol Aging.2002.23 Suppl. .1.233 -

Grimmer, T;Diehl, J;Förstl, H;Kurz, A;Drzezga, A;Schwaiger, M.Decline of cerebral glucose metabolism in patients with frontotemporal dementia a follow-up study.Neurobiol Aging.2002.23 Suppl. .1.1709 -

Grimmer, T;Diehl, J;Kurz, A;Förstl, H;Schwaiger, M;Drzezga, A.Region-specific association between cerebral glucose uptake and cognitive performance in patients with frontotemporal dementia..J Nucl Med.2002.43 Suppl. .5.990 -

Drzezga, A;Grimmer, T;Wermke, M;Storp, C;Förstl, H;Schwaiger, M;Kurz, A.Cerebral activation during navigation in a virtual reality environment. A parametric study using (H2O)-O-15-PET..J Nucl Med.2002.43 Suppl. .5.1020 -

Drzezga, A;Grimmer, T;Siebner, H;Minoshima, S;Schwaiger, M;Kurz, A.Prominent hypometabolism of the right temporoparietal and frontal cortex in two left-handed patients with primary progressive aphasia..J Neurol.2002.249.9.1263-7

Diehl, J;Kurz, A.Update on vascular dementias.Aktuelle Neurologie.2002.29.10.483-489

Lilienfeld, S;Kurz, A.Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease treated with galantamine..Ann N Y Acad Sci.2002.977.487-92

Kurz, A.A novel treatment for patients with Alzheimer's disease and with vascular dementia..Ann N Y Acad Sci.2002.977.476-81

Leucht, S;McGrath, J;White, P;Kissling, W.Carbamazepine augmentation for schizophrenia: how good is the evidence?.J Clin Psychiatry.2002.63.3.218-24